Literature DB >> 20143200

Glycogen synthase kinase 3β and its phosphorylated form (Y216) in the paraquat-induced model of parkinsonism.

Martyna Songin1, Joanna B Strosznajder, Magdalena Fitał, Katarzyna Kuter, Wacław Kolasiewicz, Przemysław Nowak, Krystyna Ossowska.   

Abstract

Parkinson's disease is a slowly progressing disease, due to a lesion of dopaminergic neurons in the substantia nigra and a dramatic loss of dopamine in the striatum. It is now accepted that several environmental agents including the herbicide paraquat (PQ) may contribute to its pathogenesis. However, till now nothing is known about the role of glycogen synthase kinase-3β (GSK-3β) in the PQ toxicity. Therefore, the aim of this study was to examine the influence of 37-week administration of PQ in rats on the immunohistochemically measured levels of the total GSK-3β and its active, tyrosine 216 (pY216)-phosphorylated form in subcellular fractions of the midbrain with pons, as well as of the striatum. The present results revealed that the long-term PQ administration increased the levels of total and active forms of GSK-3β in the midbrain with pons, whereas decreased them in the striatum. Examination of the lesion extent showed a decrease in the number of tyrosine-immunoreactive neurons in the substantia nigra pars compacta, ventral tegmental area, and locus coeruleus, as well as lower DOPAC/dopamine ratio and noradrenaline level in the striatum in rats treated with PQ. The long-term PQ administration disturbed also motor activity of rats. Summarizing, the present data indicate that the long-term exposure of rats to PQ, a commonly used herbicide, diversely alters levels of GSK-3β in different brain structures, which may be associated with their vulnerability to its toxicity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20143200     DOI: 10.1007/s12640-010-9153-7

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  71 in total

1.  Degeneration of dopaminergic mesocortical neurons and activation of compensatory processes induced by a long-term paraquat administration in rats: implications for Parkinson's disease.

Authors:  K Ossowska; M Smiałowska; K Kuter; J Wierońska; B Zieba; J Wardas; P Nowak; J Dabrowska; A Bortel; I Biedka; G Schulze; H Rommelspacher
Journal:  Neuroscience       Date:  2006-06-22       Impact factor: 3.590

2.  Environmental risk factors and Parkinson's disease: a case-control study in Taiwan.

Authors:  H H Liou; M C Tsai; C J Chen; J S Jeng; Y C Chang; S Y Chen; R C Chen
Journal:  Neurology       Date:  1997-06       Impact factor: 9.910

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Influence of paraquat on dopaminergic transporter in the rat brain.

Authors:  Krystyna Ossowska; Jadwiga Wardas; Katarzyna Kuter; Przemysław Nowak; Joanna Dabrowska; Aleksandra Bortel; Łukasz Labus; Adam Kwieciński; Anna Krygowska-Wajs; Stainsław Wolfarth
Journal:  Pharmacol Rep       Date:  2005 May-Jun       Impact factor: 3.024

5.  Increased synaptosomal dopamine content and brain concentration of paraquat produced by selective dithiocarbamates.

Authors:  Brian K Barlow; Mona J Thiruchelvam; Lisa Bennice; Deborah A Cory-Slechta; Nazzareno Ballatori; Eric K Richfield
Journal:  J Neurochem       Date:  2003-05       Impact factor: 5.372

6.  Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype.

Authors:  Mona Thiruchelvam; Alison McCormack; Eric K Richfield; Raymond B Baggs; A William Tank; Donato A Di Monte; Deborah A Cory-Slechta
Journal:  Eur J Neurosci       Date:  2003-08       Impact factor: 3.386

7.  Toxic influence of subchronic paraquat administration on dopaminergic neurons in rats.

Authors:  Katarzyna Kuter; Maria Smiałowska; Joanna Wierońska; Barbara Zieba; Jadwiga Wardas; Małgorzata Pietraszek; Przemysław Nowak; Izabela Biedka; Wojciech Roczniak; Jolanta Konieczny; Stanisław Wolfarth; Krystyna Ossowska
Journal:  Brain Res       Date:  2007-04-12       Impact factor: 3.252

8.  Influence of age on the passage of paraquat through the blood-brain barrier in rats: a distribution and pathological examination.

Authors:  P S Widdowson; M J Farnworth; M G Simpson; E A Lock
Journal:  Hum Exp Toxicol       Date:  1996-03       Impact factor: 2.903

9.  Paraquat induces long-lasting dopamine overflow through the excitotoxic pathway in the striatum of freely moving rats.

Authors:  K Shimizu; K Matsubara; K Ohtaki; S Fujimaru; O Saito; H Shiono
Journal:  Brain Res       Date:  2003-06-27       Impact factor: 3.252

10.  Paraquat is excluded by the blood brain barrier in rhesus macaque: An in vivo pet study.

Authors:  Rachel M Bartlett; James E Holden; R Jerome Nickles; Dhanabalan Murali; David L Barbee; Todd E Barnhart; Bradley T Christian; Onofre T DeJesus
Journal:  Brain Res       Date:  2008-12-24       Impact factor: 3.252

View more
  4 in total

1.  Zebrafish as an Animal Model for Drug Discovery in Parkinson's Disease and Other Movement Disorders: A Systematic Review.

Authors:  Rita L Vaz; Tiago F Outeiro; Joaquim J Ferreira
Journal:  Front Neurol       Date:  2018-06-01       Impact factor: 4.003

Review 2.  Role of neurotoxicants in the pathogenesis of Alzheimer's disease: a mechanistic insight.

Authors:  Fatema Yasmin Nisa; Md Atiar Rahman; Md Amjad Hossen; Mohammad Forhad Khan; Md Asif Nadim Khan; Mumtahina Majid; Farjana Sultana; Md Areeful Haque
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

Review 3.  Targeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotection/repair in Parkinson's disease.

Authors:  Francesca L'Episcopo; Cataldo Tirolo; Salvo Caniglia; Nuccio Testa; Maria Concetta Morale; Maria Francesca Serapide; Stefano Pluchino; Bianca Marchetti
Journal:  J Mol Cell Biol       Date:  2014-01-14       Impact factor: 6.216

Review 4.  GSK-3 as potential target for therapeutic intervention in cancer.

Authors:  James A McCubrey; Linda S Steelman; Fred E Bertrand; Nicole M Davis; Melissa Sokolosky; Steve L Abrams; Giuseppe Montalto; Antonino B D'Assoro; Massimo Libra; Ferdinando Nicoletti; Roberta Maestro; Jorg Basecke; Dariusz Rakus; Agnieszka Gizak; Zoya N Demidenko; Lucio Cocco; Alberto M Martelli; Melchiorre Cervello
Journal:  Oncotarget       Date:  2014-05-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.